Simplify Health Care ETF
Simplify Health Care ETF reported 57 holdings worth US$359M as of Jun 30, 2026 (Form N-PORT)
As of Jun 30, 2026 · Filed Aug 24, 2026
Simplify Health Care ETF reported 57 holdings worth US$359M as of Jun 30, 2026. Largest: Purecycle Technologies, Inc., United Therapeutics Corporation and Novo Nordisk A/s Class B. Filed Aug 24, 2026 (Form N-PORT).
- Holdings
- 57
- Value as reported
- US$359M
The filing in full
| Company | Shares | Value as reported | % of portfolio |
|---|
| Purecycle Technologies, Inc. | 3.05M | US$24.7M | 6.9% |
| United Therapeutics Corporation | 45,411 | US$24.6M | 6.9% |
| Novo Nordisk A/s Class B | 512K | US$24.2M | 6.8% |
| Eli Lilly And Company | 17,678 | US$21.2M | 5.9% |
| Unitedhealth Group Incorporated | 49,695 | US$20.7M | 5.8% |
| Warby Parker Inc. | 646K | US$19.6M | 5.5% |
| Johnson & Johnson | 76,957 | US$19.5M | 5.5% |
| Jazz Pharmaceuticals Plc | 68,560 | US$16.5M | 4.6% |
| Abbvie Inc. | 64,461 | US$16.2M | 4.5% |
| Biohaven Ltd. | 1.04M | US$15.5M | 4.3% |
| Benitec Biopharma Inc. | 1.01M | US$13.5M | 3.8% |
| Thermo Fisher Scientific Inc | 23,079 | US$11.6M | 3.2% |
| Align Technology, Inc. | 66,847 | US$11.3M | 3.1% |
| 10x Genomics, Inc. | 293K | US$11.2M | 3.1% |
| Quest Diagnostics Incorporated | 49,715 | US$10.5M | 2.9% |
| Gilead Sciences, Inc. | 81,325 | US$10.3M | 2.9% |
| Elevance Health, Inc. | 25,295 | US$9.78M | 2.7% |
| Danaher Corporation | 42,834 | US$8.16M | 2.3% |
| Amgen Inc. | 20,974 | US$7.6M | 2.1% |
| Cvs Health Corporation | 69,556 | US$7.2M | 2.0% |
| Astrazeneca Plc | 34,188 | US$6.48M | 1.8% |
| Cardinal Health, Inc. | 26,924 | US$6.4M | 1.8% |
| Establishment Labs Holdings Inc. | 60,540 | US$5.19M | 1.4% |
| Vertex Pharmaceuticals Incorporated | 10,456 | US$5.19M | 1.4% |
| Eyepoint, Inc. | 361K | US$5.17M | 1.4% |
| Guardant Health, Inc. | 27,571 | US$4.14M | 1.2% |
| Ge Healthcare Technologies Inc. | 52,040 | US$3.33M | 0.93% |
| Intuitive Surgical, Inc. | 7,492 | US$2.98M | 0.83% |
| Pacira Biosciences, Inc. | 83,083 | US$2.11M | 0.59% |
| Abbott Laboratories | 20,546 | US$1.86M | 0.52% |
| Edwards Lifesciences Corporation | 18,668 | US$1.69M | 0.47% |
| Insmed Incorporated | 13,547 | US$1.44M | 0.40% |
| Tg Therapeutics, Inc. | 21,269 | US$1.17M | 0.33% |
| The Cooper Companies, Inc. | 13,182 | US$945K | 0.26% |
| Agilon Health, Inc. | 8,429 | US$903K | 0.25% |
| Stryker Corporation | 2,250 | US$708K | 0.20% |
| Boston Scientific Corporation | 15,014 | US$641K | 0.18% |
| Fulcrum Therapeutics, Inc. | 154K | US$563K | 0.16% |
| Neurocrine Biosciences, Inc. | 3,315 | US$559K | 0.16% |
| Zimmer Biomet Holdings, Inc. | 4,395 | US$378K | 0.11% |
| Fluor Corporation | 6,233 | US$327K | 0.09% |
| Icon Plc | 1,499 | US$260K | 0.07% |
| Teleflex Incorporated | 1,469 | US$186K | 0.05% |
| Sarepta Therapeutics, Inc. | 7,693 | US$138K | 0.04% |
| Praxis Precision Medicines, Inc. | 372 | US$125K | 0.03% |
| Veralto Corp | 768 | US$68,106 | 0.02% |
| Bristol-myers Squibb Company | 1,100 | US$63,382 | 0.02% |
| Regeneron Pharmaceuticals, Inc. | 78 | US$48,636 | 0.01% |
| Healthequity, Inc. | 404 | US$36,489 | 0.01% |
| Abivax Sa | 220 | US$29,317 | <0.01% |
| Syndax Pharmaceuticals, Inc. | 808 | US$17,663 | <0.01% |
| Cypherpunk Technologies Inc. | 27,979 | US$17,132 | <0.01% |
| Embecta Corp. | 2,930 | US$9,552 | <0.01% |
| Apellis Pharmaceuticals, Inc. | 0 | US$0 | 0.00% |
| Alignment Healthcare, Inc. | 0 | US$0 | 0.00% |
| 3m Company | 0 | US$0 | 0.00% |
| Chugai Pharmaceutical Co., Ltd. | 0 | US$0 | 0.00% |
Source
View original at SEC
Related